NRC Health
NRC
$18.62
-$0.31-1.64%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -1.11% | 1.69% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.11% | 1.69% | |||
| Cost of Revenue | -2.07% | 12.34% | |||
| Gross Profit | -0.48% | -4.26% | |||
| SG&A Expenses | 72.26% | -36.52% | |||
| Depreciation & Amortization | 1.12% | -2.28% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 22.47% | -11.16% | |||
| Operating Income | -50.82% | 46.34% | |||
| Income Before Tax | 33.96% | -47.89% | |||
| Income Tax Expenses | -21.35% | -31.61% | |||
| Earnings from Continuing Operations | 79.20% | -56.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 79.20% | -56.38% | |||
| EBIT | -50.82% | 46.34% | |||
| EBITDA | -42.55% | 35.60% | |||
| EPS Basic | 83.55% | -57.23% | |||
| Normalized Basic EPS | -55.88% | 60.67% | |||
| EPS Diluted | 94.99% | -60.11% | |||
| Normalized Diluted EPS | -56.08% | 60.50% | |||
| Average Basic Shares Outstanding | 0.06% | -1.55% | |||
| Average Diluted Shares Outstanding | 0.48% | -1.46% | |||
| Dividend Per Share | 0.00% | 33.33% | |||
| Payout Ratio | -0.25% | 1.23% | |||